Mitsui & Co. and Rohto Pharmaceutical will acquire shares in Eu Yan Sang International, a Singapore-based traditional Chinese medicine manufacturing and sales company that operates Eu Yan Sang.
A special purpose company, jointly owned by both companies, will acquire all shares owned by Singapore’s Lytus Crane Holdings. The remaining 14% will be acquired through a public takeover bid after the completion of the transfer. In addition, the founding family will also reinvest in the special purpose company. The final effective shareholding ratios are expected to be approximately 60% for Rohto Pharmaceutical, 30% for Mitsui & Co., and 10% for the founding family. The total amount for the share acquisition is estimated to be 800 million Singapore dollars.
Eu Yan Sang International, established in 1879, is the largest manufacturer and retailer of traditional Chinese medicine in Southeast Asia, operating over 170 stores and 30 traditional Chinese medicine clinics in Singapore, Hong Kong, and Malaysia.
Notice
This article was generated using automatic translation by GPT-4 API. The translation may not be accurate.
